Tactile Systems Technology, Inc. (TCMD)
USD 13.63
(-1.66%)
USD 13.63
(-1.66%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 24.54 Million USD | 1366.01% |
| 2022 | -9.2 Million USD | -12.77% |
| 2021 | 1.91 Million USD | 330.1% |
| 2020 | -834 Thousand USD | -105.94% |
| 2019 | 14.03 Million USD | 111.86% |
| 2018 | 2.99 Million USD | 15.28% |
| 2017 | 3.89 Million USD | 13.33% |
| 2016 | 5.07 Million USD | 18.54% |
| 2015 | 4.27 Million USD | -5.04% |
| 2014 | 4.5 Million USD | 51.94% |
| 2013 | 2.96 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -1.33 Million USD | -109.94% |
| 2024 Q3 | 6.78 Million USD | 12.63% |
| 2024 Q2 | 7.56 Million USD | 668.42% |
| 2023 Q1 | -2.17 Million USD | -123.04% |
| 2023 Q2 | 3.69 Million USD | 269.87% |
| 2023 Q4 | 13.94 Million USD | 74.5% |
| 2023 FY | - USD | 1366.01% |
| 2023 Q3 | 7.98 Million USD | 116.04% |
| 2022 Q4 | 9.44 Million USD | 298.15% |
| 2022 Q2 | -2.34 Million USD | 69.99% |
| 2022 FY | - USD | -12.77% |
| 2022 Q1 | -7.8 Million USD | -285.39% |
| 2022 Q3 | 2.37 Million USD | 201.32% |
| 2021 Q3 | -504 Thousand USD | -190.16% |
| 2021 Q2 | 559 Thousand USD | 116.29% |
| 2021 FY | - USD | 330.1% |
| 2021 Q1 | -3.43 Million USD | -149.09% |
| 2021 Q4 | 4.21 Million USD | 935.32% |
| 2020 Q1 | -3.72 Million USD | -161.51% |
| 2020 Q3 | 2.44 Million USD | 133.77% |
| 2020 Q4 | 6.99 Million USD | 185.81% |
| 2020 FY | - USD | -105.94% |
| 2020 Q2 | -7.24 Million USD | -94.65% |
| 2019 Q4 | 6.04 Million USD | 53.02% |
| 2019 FY | - USD | 111.86% |
| 2019 Q3 | 3.95 Million USD | 1.75% |
| 2019 Q2 | 3.88 Million USD | 582.01% |
| 2019 Q1 | -806 Thousand USD | -137.73% |
| 2018 FY | - USD | 15.28% |
| 2018 Q2 | 2.53 Million USD | 285.85% |
| 2018 Q1 | -1.36 Million USD | -127.68% |
| 2018 Q3 | 2.15 Million USD | -14.91% |
| 2018 Q4 | 2.13 Million USD | -0.97% |
| 2017 Q2 | 1.09 Million USD | 141.61% |
| 2017 Q1 | -2.63 Million USD | -180.01% |
| 2017 Q3 | 1.58 Million USD | 44.34% |
| 2017 Q4 | 4.92 Million USD | 211.44% |
| 2017 FY | - USD | 13.33% |
| 2016 Q4 | 3.29 Million USD | 171.62% |
| 2016 FY | - USD | 18.54% |
| 2016 Q2 | 2.01 Million USD | 228.13% |
| 2016 Q3 | 1.21 Million USD | -39.94% |
| 2016 Q1 | -1.57 Million USD | -145.65% |
| 2015 Q3 | 1.67 Million USD | 281.96% |
| 2015 Q2 | 438 Thousand USD | 134.14% |
| 2015 Q1 | -1.28 Million USD | -128.9% |
| 2015 FY | - USD | -5.04% |
| 2015 Q4 | 3.45 Million USD | 106.22% |
| 2014 Q2 | -360 Thousand USD | 0.0% |
| 2014 FY | - USD | 51.94% |
| 2014 Q4 | 4.44 Million USD | 465.61% |
| 2014 Q1 | -360 Thousand USD | 0.0% |
| 2014 Q3 | 785 Thousand USD | 318.06% |
| 2013 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Acutus Medical, Inc. | -13.48 Million USD | 281.96% |
| Cerus Corporation | -26.53 Million USD | 192.482% |
| OrthoPediatrics Corp. | -8.38 Million USD | 392.817% |
| PetVivo Holdings, Inc. | -10.49 Million USD | 333.847% |
| Talis Biomedical Corporation | -66.04 Million USD | 137.158% |
| Vivos Therapeutics, Inc. | -16.67 Million USD | 247.172% |
| Inogen, Inc. | -45.67 Million USD | 153.725% |
| Spectral AI, Inc. | -12.26 Million USD | 300.139% |
| Nano-X Imaging Ltd. | -47.69 Million USD | 151.456% |
| CVRx, Inc. | -38.73 Million USD | 163.363% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | 795.607% |
| Helius Medical Technologies, Inc. | -12.1 Million USD | 302.701% |
| Orthofix Medical Inc. | -86.98 Million USD | 128.213% |
| Venus Concept Inc. | -26.11 Million USD | 193.98% |
| Accelerate Diagnostics, Inc. | -49.77 Million USD | 149.308% |
| Bioventus Inc. | -23.07 Million USD | 206.376% |
| BrainsWay Ltd. | -2.31 Million USD | 1161.921% |
| Envoy Medical, Inc. | -18.23 Million USD | 234.56% |
| electroCore, Inc. | -17.76 Million USD | 238.181% |
| IceCure Medical Ltd | -15.25 Million USD | 260.893% |
| Lucid Diagnostics Inc. | -49.75 Million USD | 149.328% |
| Monogram Orthopaedics, Inc. | -16.85 Million USD | 245.595% |
| MaxCyte, Inc. | -44.12 Million USD | 155.613% |
| NeuroOne Medical Technologies Corporation | -11.75 Million USD | 308.753% |
| Nexalin Technology, Inc. | -5.69 Million USD | 531.146% |
| PAVmed Inc | -75.74 Million USD | 132.401% |
| Rapid Micro Biosystems, Inc. | -53.75 Million USD | 145.651% |
| RxSight, Inc. | -41.03 Million USD | 159.802% |
| Sight Sciences, Inc. | -49.41 Million USD | 149.663% |
| SI-BONE, Inc. | -34.44 Million USD | 171.245% |
| TELA Bio, Inc. | -40.63 Million USD | 160.397% |
| TriSalus Life Sciences, Inc. | -58.29 Million USD | 142.096% |
| Treace Medical Concepts, Inc. | -39 Million USD | 162.913% |
| LivaNova PLC | 39.01 Million USD | 37.1% |
| 908 Devices Inc. | -34.02 Million USD | 172.126% |
| Alphatec Holdings, Inc. | -110.59 Million USD | 122.191% |
| Nemaura Medical Inc. | -7.28 Million USD | 436.775% |
| NeuroPace, Inc. | -22.83 Million USD | 207.476% |
| LENSAR, Inc. | -8.71 Million USD | 381.627% |
| Apyx Medical Corporation | -18.11 Million USD | 235.496% |
| Cutera, Inc. | -136.56 Million USD | 117.971% |
| STRATA Skin Sciences, Inc. | -3.38 Million USD | 826.065% |
| BioSig Technologies, Inc. | -28.15 Million USD | 187.176% |
| Anika Therapeutics, Inc. | 2.51 Million USD | -875.397% |
| ClearPoint Neuro, Inc. | -20.98 Million USD | 216.923% |
| Integra LifeSciences Holdings Corporation | 383.56 Million USD | 93.602% |
| Axonics, Inc. | 7.77 Million USD | -215.64% |
| Outset Medical, Inc. | -153.78 Million USD | 115.958% |
| IRIDEX Corporation | -7.44 Million USD | 429.498% |
| PROCEPT BioRobotics Corporation | -98.09 Million USD | 125.018% |
| IRadimed Corporation | 20.8 Million USD | -17.982% |
| Tivic Health Systems, Inc. | -8.06 Million USD | 404.403% |
| INVO Bioscience, Inc. | -6.88 Million USD | 456.699% |
| Telesis Bio, Inc. | -40.49 Million USD | 160.606% |
| Viemed Healthcare, Inc. | 36.67 Million USD | 33.089% |
| Varex Imaging Corporation | 67.2 Million USD | 63.481% |
| Quipt Home Medical Corp. | 44.07 Million USD | 44.315% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | 325.768% |
| Pulmonx Corporation | -55.09 Million USD | 144.545% |
| Dynatronics Corporation | -976 Thousand USD | 2614.426% |
| Modular Medical, Inc. | -17.1 Million USD | 243.489% |
| ReShape Lifesciences Inc. | -14.48 Million USD | 269.424% |
| Semler Scientific, Inc. | 23.58 Million USD | -4.036% |
| InMode Ltd. | 196.28 Million USD | 87.497% |
| Bruker Corporation | 599 Million USD | 95.903% |
| Cytosorbents Corporation | -28.81 Million USD | 185.18% |
| DexCom, Inc. | 916.7 Million USD | 97.323% |
| Align Technology, Inc. | 799.03 Million USD | 96.929% |
| Viveve Medical, Inc. | -20.61 Million USD | 219.033% |
| ZimVie Inc. | 91.07 Million USD | 73.053% |
| Movano Inc. | -29.12 Million USD | 184.261% |
| Cytek Biosciences, Inc. | -4.4 Million USD | 656.738% |
| Nexalin Technology, Inc. | -5.69 Million USD | 531.146% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | 795.607% |
| Tandem Diabetes Care, Inc. | -194.65 Million USD | 112.607% |
| Profound Medical Corp. | -27.12 Million USD | 190.479% |
| Insulet Corporation | 323.6 Million USD | 92.416% |
| enVVeno Medical Corporation | -25.01 Million USD | 198.093% |
| Surmodics, Inc. | 1.18 Million USD | -1965.741% |
| iCAD, Inc. | -6.56 Million USD | 473.816% |
| Nuwellis, Inc. | -16.35 Million USD | 250.043% |
| Biotricity, Inc. | -8.82 Million USD | 377.982% |
| iRhythm Technologies, Inc. | -96.86 Million USD | 125.336% |
| Aethlon Medical, Inc. | -11.84 Million USD | 307.112% |
| InspireMD, Inc. | -20.91 Million USD | 217.359% |
| PAVmed Inc. | -75.74 Million USD | 132.401% |
| BIOLASE, Inc. | -15.13 Million USD | 262.104% |
| Beyond Air, Inc. | -59.03 Million USD | 141.573% |
| FONAR Corporation | 28.25 Million USD | 13.134% |
| AxoGen, Inc. | -13.32 Million USD | 284.131% |
| Vivani Medical, Inc. | -26.6 Million USD | 192.232% |
| Inari Medical, Inc. | 7.11 Million USD | -245.016% |
| UFP Technologies, Inc. | 72.74 Million USD | 66.263% |
| QT Imaging Holdings, Inc. | -3.38 Million USD | 824.824% |
| Heart Test Laboratories, Inc. | -6.15 Million USD | 498.652% |
| Tenon Medical, Inc. | -15.52 Million USD | 258.044% |
| Autonomix Medical, Inc. Common Stock | -15.26 Million USD | 260.756% |
| Co-Diagnostics, Inc. | -41.47 Million USD | 159.17% |
| AdaptHealth Corp. | -171.09 Million USD | 114.344% |
| Sintx Technologies, Inc. | -6.6 Million USD | 471.833% |
| NanoVibronix, Inc. | -3.43 Million USD | 814.44% |
| Quanterix Corporation | -38.08 Million USD | 164.432% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | 325.768% |
| Sensus Healthcare, Inc. | 30 Thousand USD | -81703.333% |
| Pacific Biosciences of California, Inc. | -277.28 Million USD | 108.851% |
| TransMedics Group, Inc. | -7.6 Million USD | 422.78% |
| ReWalk Robotics Ltd. | -21.76 Million USD | 212.754% |
| NeuroMetrix, Inc. | -7.09 Million USD | 445.852% |
| Hyperfine, Inc. | -47.06 Million USD | 152.147% |
| Establishment Labs Holdings Inc. | -58.3 Million USD | 142.089% |
| Biomerica, Inc. | -5.99 Million USD | 509.494% |
| Bone Biologics Corporation | 479.57 Thousand USD | -5017.271% |
| AVITA Medical, Inc. | -39.56 Million USD | 162.023% |
| Bluejay Diagnostics, Inc. | -9.17 Million USD | 367.537% |
| Silk Road Medical, Inc | -45.08 Million USD | 154.439% |